We just received data on a new analyst forecast for $CBT. Joshua Spector from UBS set a price target of 74.0 for CBT.
To track analyst ratings and price targets for $CBT, check out Quiver Quantitative's $CBT forecast page.
Should you buy $CBT?
Some analysts are better than others. To view the past performance of UBS, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$CBT Price Targets
Multiple analysts have issued price targets for $CBT recently. We have seen 3 analysts offer price targets for $CBT in the last 6 months, with a median target of $74.0.
Here are some recent targets:
- Joshua Spector from UBS set a target price of $74.0 on 01/12/2026
- John Roberts from Mizuho set a target price of $80.0 on 12/18/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $54.0 on 11/28/2025
$CBT Insider Trading Activity
$CBT insiders have traded $CBT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $CBT stock by insiders over the last 6 months:
- SEAN D KEOHANE (President and CEO) has made 0 purchases and 4 sales selling 114,436 shares for an estimated $9,072,094.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CBT Revenue
$CBT had revenues of $899M in Q4 2025. This is a decrease of -10.19% from the same period in the prior year.
You can track CBT financials on Quiver Quantitative's CBT stock page.
$CBT Hedge Fund Activity
We have seen 165 institutional investors add shares of $CBT stock to their portfolio, and 198 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS GROUP AG added 386,514 shares (+186.7%) to their portfolio in Q3 2025, for an estimated $29,394,389
- COPELAND CAPITAL MANAGEMENT, LLC removed 215,412 shares (-29.1%) from their portfolio in Q3 2025, for an estimated $16,382,082
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 204,975 shares (+61.6%) to their portfolio in Q3 2025, for an estimated $15,588,348
- AMERICAN CENTURY COMPANIES INC added 140,665 shares (+8.4%) to their portfolio in Q3 2025, for an estimated $10,697,573
- QUBE RESEARCH & TECHNOLOGIES LTD removed 126,370 shares (-42.3%) from their portfolio in Q3 2025, for an estimated $9,610,438
- VICTORY CAPITAL MANAGEMENT INC added 102,764 shares (+259.2%) to their portfolio in Q3 2025, for an estimated $7,815,202
- BARCLAYS PLC added 101,168 shares (+60.6%) to their portfolio in Q3 2025, for an estimated $7,693,826
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
